XHR(XHR)
XHR
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.12B | $1.15B | $1.18B |
| Low | $1.12B | $1.14B | $1.18B |
| High | $1.13B | $1.17B | $1.18B |
| EBITDA Avg | $415M | $427M | $437M |
| Low | $413M | $422M | $437M |
| High | $418M | $434M | $437M |
| EBIT Avg | $354M | $364M | $373M |
| Low | $352M | $359M | $372M |
| High | $356M | $370M | $373M |
| Net Income Avg | $44M | $54M | — |
| Low | $41M | $53M | — |
| High | $45M | $54M | — |
| EPS Avg | $0.45 | $0.55 | — |
| Low | $0.43 | $0.55 | — |
| High | $0.46 | $0.56 | — |
| Analysts (Rev / EPS) | 3 / 1 | 5 / 2 | 2 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $301M | $250M | $275M | $304M | $310M | $258M | $283M |
| Low | $296M | $248M | $271M | $300M | $305M | $254M | $279M |
| High | $305M | $254M | $278M | $309M | $314M | $262M | $287M |
| EBITDA Avg | $112M | $93M | $102M | $113M | $115M | $95M | $105M |
| Low | $110M | $92M | $100M | $111M | $113M | $94M | $103M |
| High | $113M | $94M | $103M | $114M | $116M | $97M | $106M |
| EBIT Avg | $95M | $79M | $87M | $96M | $98M | $81M | $89M |
| Low | $93M | $78M | $85M | $95M | $96M | $80M | $88M |
| High | $96M | $80M | $88M | $97M | $99M | $83M | $91M |
| Net Income Avg | $23M | $-9M | $7M | $28M | $24M | $-9M | $8M |
| Low | $19M | $-9M | $7M | $27M | $24M | $-9M | $8M |
| High | $28M | $-8M | $8M | $28M | $25M | $-9M | $8M |
| EPS Avg | $0.25 | $-0.10 | $0.08 | $0.30 | $0.26 | $-0.10 | $0.09 |
| Low | $0.20 | $-0.10 | $0.08 | $0.29 | $0.26 | $-0.10 | $0.09 |
| High | $0.30 | $-0.09 | $0.08 | $0.31 | $0.26 | $-0.10 | $0.09 |
| Analysts (Rev / EPS) | 5 / 2 | 5 / 2 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 |